tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BNXTF Stock Latest News

BioNxt Solutions Launches $1.2M Convertible Debenture Offering
Company AnnouncementsBioNxt Solutions Launches $1.2M Convertible Debenture Offering
4d ago
BioNxt Solutions Resumes Trading as Cease Trade Order Revoked
PremiumCompany Announcements
BioNxt Solutions Resumes Trading as Cease Trade Order Revoked
18d ago
BioNxt Solutions Launches Feasibility Study for Semaglutide Oral Thin Film
PremiumCompany Announcements
BioNxt Solutions Launches Feasibility Study for Semaglutide Oral Thin Film
20d ago
BioNxt Solutions Addresses MCTO Status Amid Filing Delays
PremiumCompany Announcements
BioNxt Solutions Addresses MCTO Status Amid Filing Delays
1M ago
BioNxt Solutions Receives Management Cease Trade Order Amidst Filing Delays
PremiumCompany Announcements
BioNxt Solutions Receives Management Cease Trade Order Amidst Filing Delays
2M ago
BioNxt Solutions Secures Key European Patent for Sublingual Drug Delivery
PremiumCompany AnnouncementsBioNxt Solutions Secures Key European Patent for Sublingual Drug Delivery
2M ago
BioNxt Solutions Provides Update on Management Cease Trade Order
Premium
Company Announcements
BioNxt Solutions Provides Update on Management Cease Trade Order
2M ago
BioNxt Expands R&D Capabilities with Munich Lab Integration
Premium
Company Announcements
BioNxt Expands R&D Capabilities with Munich Lab Integration
2M ago
BioNxt Solutions Secures Eurasian Patent for Sublingual Drug Delivery
PremiumCompany Announcements
BioNxt Solutions Secures Eurasian Patent for Sublingual Drug Delivery
2M ago
BioNxt Solutions Delays 2024 Financial Statement Filing
PremiumCompany Announcements
BioNxt Solutions Delays 2024 Financial Statement Filing
3M ago
BioNxt Solutions Advances Human Bioequivalence Study for MS Treatment
PremiumCompany Announcements
BioNxt Solutions Advances Human Bioequivalence Study for MS Treatment
3M ago
BioNxt Solutions Completes $2.5 Million Convertible Debenture Offering
PremiumCompany Announcements
BioNxt Solutions Completes $2.5 Million Convertible Debenture Offering
4M ago
BioNxt Solutions Secures $2.5 Million Through Convertible Debenture Offering
PremiumCompany AnnouncementsBioNxt Solutions Secures $2.5 Million Through Convertible Debenture Offering
4M ago
BioNxt Solutions Secures $1.6 Million in Convertible Debenture Placement
Premium
Company Announcements
BioNxt Solutions Secures $1.6 Million in Convertible Debenture Placement
5M ago
BioNxt Solutions Sets Strategic 90-Day Plan with Patent, Clinical, and Market Expansions
Premium
Company Announcements
BioNxt Solutions Sets Strategic 90-Day Plan with Patent, Clinical, and Market Expansions
5M ago
BioNxt Solutions Strengthens Board and Amends Warrants
PremiumCompany Announcements
BioNxt Solutions Strengthens Board and Amends Warrants
5M ago
BioNxt Solutions Completes $3 Million Convertible Debenture Placement
PremiumCompany Announcements
BioNxt Solutions Completes $3 Million Convertible Debenture Placement
6M ago
BioNxt Solutions Extends Debenture Maturity Date and Issues Shares
PremiumCompany Announcements
BioNxt Solutions Extends Debenture Maturity Date and Issues Shares
6M ago
BioNxt Solutions Completes Significant Funding Round
PremiumCompany Announcements
BioNxt Solutions Completes Significant Funding Round
7M ago
BioNxt Solutions Raises $2.11 Million in Debentures
PremiumCompany AnnouncementsBioNxt Solutions Raises $2.11 Million in Debentures
7M ago
BioNxt Solutions Expands Patent Portfolio and Plans Trials
Premium
Company Announcements
BioNxt Solutions Expands Patent Portfolio and Plans Trials
7M ago
BioNxt Solutions Advances Multiple Sclerosis Treatment
Premium
Company Announcements
BioNxt Solutions Advances Multiple Sclerosis Treatment
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >